
Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons
Author(s) -
Allan Kristensen,
Manan Pareek,
Kristian Kragholm,
Thomas S G Sehested,
Michael Hecht Olsen,
Eva Prescott
Publication year - 2022
Publication title -
cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.547
H-Index - 63
eISSN - 1421-9751
pISSN - 0008-6312
DOI - 10.1159/000524948
Subject(s) - clinical endpoint , medicine , myocardial infarction , unstable angina , clinical trial , cardiology , acute coronary syndrome
Unstable angina (UA) is a component of acute coronary syndrome that is only occasionally included in primary composite endpoints in clinical cardiovascular trials. The aim of this paper is to elucidate the potential benefits and disadvantages of including UA in such contexts.